Genetic Screening

The FDA is warning the public about the risks for false results and inappropriate interpretation of results from noninvasive prenatal screening tests, which could lead to “improper medical decisions,” according to the agency.

Multigene germline genetic testing should be considered for all patients with advanced cancer to better guide treatment selection, according to study results published in Journal of Clinical Oncology.

Anita Kinney, PhD, has been chosen president-elect of American Society of Preventive Oncology, which advocates for cancer prevention and control research.

The virtual National Lipid Association Scientific Session, held Dec. 10 to 12, covered topics such as dyslipidemia during pregnancy, genetic testing and the ethical concerns of lipidologists.

Genetic modifiers — many discovered in the late 1990s — can be “harnessed” to better understand the processes and mechanisms behind weight gain and one day even regulate appetite, according to a speaker.

An LPA genetic risk score with 43 single nucleotide variants provided similar risk prediction for atherosclerotic CVD compared with measuring lipoprotein(a), researchers found.

Researchers identified 14 novel genetic associations for abdominal aortic aneurysm that when added to a polygenic risk score may find more patients at increased risk for the condition.

A machine learning algorithm to identify patients with familial hypercholesterolemia was successfully implemented in a large health care system, according to a presentation.

The time to begin screening all newborns for genetic risk is now.

The etiology of type 1 diabetes continues to be debated, although experts agree it is likely a mix of genetic and environmental causes. Today, more than 50 regions of the human genome are implicated in type 1 diabetes.